HomeCompareESGRP vs JNJ

ESGRP vs JNJ: Dividend Comparison 2026

ESGRP yields 8.54% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ESGRP wins by $2.50M in total portfolio value
10 years
ESGRP
ESGRP
● Live price
8.54%
Share price
$20.48
Annual div
$1.75
5Y div CAGR
46.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.53M
Annual income
$1,693,295.50
Full ESGRP calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — ESGRP vs JNJ

📍 ESGRP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodESGRPJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ESGRP + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ESGRP pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ESGRP
Annual income on $10K today (after 15% tax)
$726.32/yr
After 10yr DRIP, annual income (after tax)
$1,439,301.18/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, ESGRP beats the other by $1,435,263.78/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ESGRP + JNJ for your $10,000?

ESGRP: 50%JNJ: 50%
100% JNJ50/50100% ESGRP
Portfolio after 10yr
$1.28M
Annual income
$849,022.69/yr
Blended yield
66.41%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ESGRP
No analyst data
Altman Z
0.9
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ESGRP buys
0
JNJ buys
0
No recent congressional trades found for ESGRP or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricESGRPJNJ
Forward yield8.54%2.14%
Annual dividend / share$1.75$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR46.9%28%
Portfolio after 10y$2.53M$30.5K
Annual income after 10y$1,693,295.50$4,749.88
Total dividends collected$2.42M$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ESGRP vs JNJ ($10,000, DRIP)

YearESGRP PortfolioESGRP Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,955$1,255.25$10,594$274.49+$1.4KESGRP
2$14,852$2,060.28$11,294$360.69+$3.6KESGRP
3$19,406$3,514.01$12,133$476.91+$7.3KESGRP
4$27,068$6,303.50$13,156$635.42+$13.9KESGRP
5$41,034$12,070.86$14,432$854.61+$26.6KESGRP
6$69,028$25,122.32$16,056$1,162.76+$53.0KESGRP
7$131,881$58,020.98$18,175$1,604.53+$113.7KESGRP
8$293,300$152,187.52$21,009$2,252.68+$272.3KESGRP
9$778,504$464,672.26$24,911$3,229.73+$753.6KESGRP
10$2,526,294$1,693,295.50$30,458$4,749.88+$2.50MESGRP

ESGRP vs JNJ: Complete Analysis 2026

ESGRPStock

Enstar Group Limited acquires and manages insurance and reinsurance companies, and portfolios of insurance and reinsurance business in run-off. It engages in the run-off property and casualty, and other non-life lines insurance businesses. The company also provides consulting services, including claims inspection, claims validation, reinsurance asset collection, syndicate management, and IT consulting services to the insurance and reinsurance industry. It operates in Bermuda, the United States, the United Kingdom, Australia, and other Continental European countries. The company was formerly known as Castlewood Holdings Limited and changed its name to Enstar Group Limited in January 2007. The company was founded in 1993 and is headquartered in Hamilton, Bermuda.

Full ESGRP Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this ESGRP vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ESGRP vs SCHDESGRP vs JEPIESGRP vs OESGRP vs KOESGRP vs MAINESGRP vs ABBVESGRP vs MRKESGRP vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.